Cyclooxygenases in Reproductive Medicine and Biology

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of the Society for Gynecologic Investigation

• Publication date

  1999-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/107155769900600602PMID 10643580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COX-2 inhibitors.

  1999cited by this paper
• Arachidonic Acid Is Preferentially Metabolized by Cyclooxygenase-2 to Prostacyclin and Prostaglandin E2 *

  1999cited by this paper
• Inducible cyclooxygenase may have anti-inflammatory properties

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• Cox-2-selective inhibitors: the new super aspirins.

  1999cited by this paper
• Tumour necrosis factor-alpha stimulates increased expression of prostaglandin endoperoxide H synthase Type 2 mRNA in amnion-derived WISH cells.

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

  1998cited by this paper
• Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3'-untranslated region.

  1998cited by this paper
• Opposing actions of prostaglandins and oxytocin determine the onset of murine labor.

  1998cited by this paper
• Cyclooxygenase in biology and disease

  1998cited by this paper
• Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease.

  1997cited by this paper
• Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium.

  1997cited by this paper
• Tumour necrosis factor-alpha induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts: suppression by glucocorticoids and NSAIDs.

  1997cited by this paper
• Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice.

  1997cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• Potential sites of prostaglandin actions in the periimplantation mouse uterus: differential expression and regulation of prostaglandin receptor genes.

  1997cited by this paper
• The discovery and function of COX-2.

  1997cited by this paper
• Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer

  1997cited by this paper
• Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in nonpregnant ovine myometrium and endometrium in vivo.

  1997cited by this paper
• Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery.

  1997cited by this paper
• Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage

  1997cited by this paper
• Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

  1997cited by this paper
• Tumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDs.

  1997cited by this paper
• Cyclooxygenase-2 gene expression in human breast cancer.

  1997cited by this paper
• Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

  1997cited by this paper
• Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in hum an tracheal epithelial cells in vitro.

  1996cited by this paper
• COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex.

  1996cited by this paper
• Cyclooxygenase‐2 Induction in Cerebral Cortex: An Intracellular Response to Synaptic Excitation

  1996cited by this paper
• Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids.

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Regulation of the estrogen receptor and its messenger ribonucleic acid in the ovariectomized sheep myometrium and endometrium: the role of estradiol and progesterone.

  1996cited by this paper
• Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells.

  1996cited by this paper
• Prostaglandins and menstruation.

  1996cited by this paper
• Prostaglandin endoperoxide H synthases-1 and -2.

  1996cited by this paper
• Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course.

  1996cited by this paper
• Selective Induction of Prostaglandin G/H Synthase I by Stem Cell Factor and Dexamethasone in Mast Cells (*)

  1995cited by this paper
• Interleukin-1 beta induces cyclooxygenase-2 in cultured human decidual cells.

  1995cited by this paper
• Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

  1995cited by this paper
• Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

  1995cited by this paper
• Mediation of inflammation by cyclooxygenase-2.

  1995cited by this paper
• Studies on glucocorticoid hormone actions in the regulation of human amnion PGHS.

  1995cited by this paper
• Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide.

  1995cited by this paper
• Indomethacin.

  1995cited by this paper
• Dexamethasone suppression of IL-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells.

  1994cited by this paper
• Pharmacology of Prostaglandin Endoperoxide Synthase Isozymes‐1 and‐2 a

  1994cited by this paper
• Prostaglandin-endoperoxide synthase

  1994cited by this paper
• The tis genes, primary response genes induced by growth factors and tumor promoters in 3T3 cells.

  1994cited by this paper
• The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term.

  1994cited by this paper
• Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression.

  1994cited by this paper
• Characterization of the promoter of human prostaglandin H synthase-1 gene.

  1993cited by this paper
• N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum.

  1993cited by this paper
• The Molecular Basis of Eicosanoid Action

  1993cited by this paper
• Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids.

  1993cited by this paper
• Neonatal complications after the administration of indomethacin for preterm labor

  1993cited by this paper
• Drug inhibition and cellular regulation of prostaglandin G/H synthase isoenzyme 2.

  1993cited by this paper
• Lipid mediators of implantation and decidualization.

  1993cited by this paper
• Chromosomal organization of the inducible and constitutive prostaglandin synthase/cyclooxygenase genes in mouse.

  1993cited by this paper
• Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences.

  1992cited by this paper
• Prostaglandins and Implantation

  1992cited by this paper
• Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.

  1992cited by this paper
• Prostaglandin endoperoxide synthase: structure and catalysis.

  1991cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.

  1991cited by this paper
• Prostaglandin-E2 released by pre-implantation human conceptuses.

  1990cited by this paper
• Immunohistochemical localization of prostaglandin H synthase in the embryo and uterus of the mouse from ovulation through implantation

  1990cited by this paper
• Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases.

  1989cited by this paper
• The eicosanoids and their biochemical mechanisms of action.

  1989cited by this paper
• A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

  1986cited by this paper
• Arachidonic acid metabolism.

  1986cited by this paper
• Possible role of prostaglandin F in blastocyst implantation.

  1986cited by this paper
• How is the level of free arachidonic acid controlled in mammalian cells?

  1982cited by this paper
• Mechanism for irreversible self-deactivation of prostaglandin synthetase.

  1976cited by this paper
• Prostaglandins and inflammation in the eye.

  1976cited by this paper

• Novel oxalamide derivatives for COXs expression and breast cancer: design, synthesis, biological evaluation, and docking studies

  2023cites this paper
• Clinical Use of COX-2 Inhibitors containing Quinoline Heterocycle as a Selective Therapeutic Agents for Complementary Medicine

  2023cites this paper
• Effects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer

  2020cites this paper
• Progesterone Receptor Signaling Selectively Modulates Cytokine-Induced Global Gene Expression in Human Cervical Stromal Cells

  2020cites this paper
• Investigation of the effects of centrally injected nesfatin-1 on the hypothalamic cyclooxygenase and lipoxygenase enzymes using western blotting

  2019cites this paper
• A microfluidic approach to investigate changes in functional properties of nociceptive axons underlying inflammatory pain states

  2018cites this paper
• Loss of luteotropic prostaglandin E plays an important role in the regulation of luteolysis in women

  2017influential citation
• Kinetic effect of oestrogen on secretion of prostaglandins E2 and F2α in bovine oviduct epithelial cells.

  2017cites this paper
• Kinetic effect of oestrogen on secretion of prostaglandins E2 and F2? in bovine oviduct epithelial cells.

  2017cites this paper
• Expression of peroxisome proliferator activation receptors (PPARs) and TNFα in placenta tissues in unexplained recurrent pregnancy loss: an immunohistochemical study.

  2016cites this paper
• Lactobacillus acidophilus maintained oxidative stress from reproductive organs in collagen-induced arthritic rats

  2016cites this paper
• Glycyrrhizic Acid Attenuates Sepsis-Induced Acute Kidney Injury by Inhibiting NF-κB Signaling Pathway

  2016cites this paper
• The expression of prostaglandin-E2 and its receptor in the oviduct of Chinese brown frog (Rana dybowskii).

  2016cites this paper
• Roles of epidermal growth factor receptor and its ligands in ovarian cancer

  2015cites this paper
• Synthesis, structure–activity relationships, and bioactivity evaluation of 6-bromo-quinazolinone derivatives

  2014cites this paper
• COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion.

  2014cites this paper
• Tetrabromobisphenol A activates inflammatory pathways in human first trimester extravillous trophoblasts in vitro.

  2014cites this paper
• Synthesis and biological evaluation of new benzo-thieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives as potential selective cyclooxygenase-2 inhibitors

  2013cites this paper
• Obésité et grossesse : étude de l'influence d'un marqueur de l'obésité sur les mécanismes cellulaires et tissulaires de l'accouchement dans un modèle d'explants myométriaux humains

  2012influential citation
• Amniotic membrane induces peroxisome proliferator-activated receptor-γ positive alternatively activated macrophages.

  2012cites this paper
• Regulation Of Myometrial Gene Expression By Oestrogen And Progesterone: The Use Of A Cell Culture Model To Mimic The In Vivo Conditions Of Pregnant Human Uterus

  2012cites this paper
• The expression of thioredoxin-1 in preterm delivery placenta

  2012cites this paper
• Role of Nuclear Receptors Peroxisome Proliferator-Activated Receptors (PPARs) and Liver X Receptors (LXRs) in the Human Placental Pathophysiology

  2012cites this paper
• NOS-1-derived NO is an essential triggering signal for the development of systemic inflammatory responses.

  2011cites this paper
• Inflammatory Gene Regulatory Networks in Amnion Cells Following Cytokine Stimulation: Translational Systems Approach to Modeling Human Parturition

  2011cites this paper
• A maternal high-fat diet represses the expression of antioxidant defense genes and induces the cellular senescence pathway in the liver of male offspring rats.

  2011cites this paper
• Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships

  2011cites this paper
• The Expression and Effect of Myoferlin Depletion in Breast Cancer Cells

  2011cites this paper
• Chorionic gonadotrophin regulates CXCR4 expression in human endometrium via E-series prostanoid receptor 2 signalling to PI3K–ERK1/2: implications for fetal–maternal crosstalk for embryo implantation

  2010cites this paper
• Nuclear factor-kappa B localization and function within intrauterine tissues from term and preterm labor and cultured fetal membranes

  2010cites this paper
• The concentrations of visfatin in the follicular fluids of women undergoing controlled ovarian stimulation are correlated to the number of oocytes retrieved.

  2010cites this paper
• Mathematical modeling of preadipocyte fate determination.

  2010cites this paper
• Transcriptional regulation of the processes of human labour and delivery.

  2009cites this paper
• COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats.

  2009cites this paper
• Paradoxical stimulation of cyclooxygenase-2 expression by glucocorticoids via a cyclic AMP response element in human amnion fibroblasts.

  2009cites this paper
• Placental Implications of Peroxisome Proliferator-Activated Receptors in Gestation and Parturition

  2008cites this paper
• Exploring cumulus-oocyte-complex-oviductal cell interactions: gene profiling in the bovine oviduct.

  2008cites this paper
• Premature labor: a state of platelet activation?

  2008cites this paper
• Paradox of Glucocorticoid-Induced Cytosolic Phospholipase A2 Group IVA Messenger RNA Expression Involves Glucocorticoid Receptor Binding to the Promoter in Human Amnion Fibroblasts1

  2008cites this paper
• Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts.

  2008cites this paper
• Mifepristone attenuates human chorionic gonadotropin-induced extracellular signal-regulated kinase 1/2 phosphorylation, cyclooxygenase-2, and prostaglandin E2 production in human granulosa luteal cells.

  2008cites this paper
• Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta.

  2008cites this paper
• Differential Regulation of Prostaglandin Production Mediated by Corticotropin-Releasing Hormone Receptor Type 1 and Type 2 in Cultured Human Placental

  2008cites this paper
• The relationship between pro-inflammatory cytokines, prostaglandins, and fetal hypothalamic-pituitary-adrenal axis activation in mares with infective pre-term delivery

  2008cites this paper
• Dose-Dependent Effects of Meloxicam Administration on Cyclooxygenase-1 and Cyclooxygenase-2 Protein Expression in Intrauterine Tissues and Fetal Tissues of a Sheep Model of Preterm Labor

  2007cites this paper
• Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor

  2007cites this paper
• Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes.

  2007cites this paper
• Antiinflammatory effects of the cyclopentenone isoprostane 15-A(2)-IsoP in human gestational tissues.

  2007cites this paper
• TOCOLYTIC EFFECT OF PARECOXIB, A NEW PARENTERAL CYCLO‐OXYGENASE‐2‐SPECIFIC INHIBITOR, ON THE SPONTANEOUS AND PROSTAGLANDIN‐INDUCED CONTRACTIONS OF RAT ISOLATED MYOMETRIUM

  2007cites this paper
• Oxidative stress, gene expression, and protein changes induced in the human placenta during labor.

  2007cites this paper
• Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.

  2007cites this paper
• Prostaglandin signaling and ovarian follicle development in the silkmoth, Bombyx mori.

  2007cites this paper
• The role and regulation of the nuclear factor kappa B signalling pathway in human labour.

  2007cites this paper
• In utero exposure to phthalates and fetal development.

  2006cites this paper
• Evidence for Interleukin‐10‐Mediated Inhibition of Cyclo‐ oxygenase‐2 Expression and Prostaglandin Production in Preterm Human Placenta

  2006cites this paper
• Leptin Suppresses Human Chorionic Gonadotropin-Induced Cyclooxygenase-2 Expression and Prostaglandin Production in Cultured Human Granulose Luteal Cells

  2006cites this paper
• Differential expression of cyclooxygenase 1 and cyclooxygenase 2 in the bovine oviduct.

  2006influential citation
• Dexamethasone fails to inhibit the induction of cytosolic phospholipase A(2) expression by interleukin-1beta in cultured primary human amnion fibroblasts.

  2006cites this paper
• Regulation of the MAFF Transcription Factor by Proinflammatory Cytokines in Myometrial Cells1

  2006cites this paper
• 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues.

  2006cites this paper
• Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta.

  2006cites this paper
• Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitors.

  2006cites this paper
• Signalling networks regulating cyclooxygenase-2.

  2006cites this paper
• prostaglandin J 2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors and and Nuclear Factor B

  2005cites this paper
• Glucocorticoid-induced apoptosis in human decidua: a novel role for 11beta-hydroxysteroid dehydrogenase in late gestation.

  2005cites this paper
• Expression of cyclooxygenase isoforms in developing rat placenta, human term placenta, and BeWo human trophoblast model.

  2005cites this paper
• New insights into COX-2 biology and inhibition.

  2005cites this paper
• Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.

  2005cites this paper
• Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.

  2005cites this paper
• Clinical pharmacology of etoricoxib

  2005cites this paper
• Modulation of Cytokine-Induced Cyclooxygenase 2 Expression by PPARG Ligands Through NFκB Signal Disruption in Human WISH and Amnion Cells1

  2005cites this paper
• Cyclooxygenase-2 (COX-2) expression by in vitro produced bovine embryos. Preliminary results

  2005cites this paper
• Nanomolar and micromolar effects of 15-deoxy- ∆ 12,14 -Prostaglandin J 2 on amnion-derived WISH epithelial cells: differential roles of PPAR- γ , – δ and NF- κ B * Molecular Fast Forward.

  2005cites this paper
• Nuclear prostaglandin receptors: role in pregnancy and parturition?

  2004cites this paper
• Clinical pharmacology of novel selective COX-2 inhibitors.

  2004cites this paper
• Epidermal Growth Factor and Interleukin-1β Utilize Divergent Signaling Pathways to Synergistically Upregulate Cyclooxygenase-2 Gene Expression in Human Amnion-Derived WISH Cells1

  2004cites this paper
• IFN‐γ‐Mediated Inhibition of COX‐2 Expression in the Placenta from Term and Preterm Labor Pregnancies

  2004cites this paper
• Cyclooxygenase enzymes: regulation and function.

  2004cites this paper
• Sperm-Induced Modification of the Oviductal Gene Expression Profile After Natural Insemination in Mice1

  2004cites this paper
• REPRODUCTIONRESEARCH Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle

  2004cites this paper
• Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways.

  2004cites this paper
• Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.

  2004cites this paper
• Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium.

  2004cites this paper
• Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition.

  2004cites this paper
• Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.

  2004cites this paper
• Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

  2004cites this paper
• Prostaglandin E2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway.

  2003cites this paper
• Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells.

  2003cites this paper
• Dysmenorrhea treatment with a single daily dose of rofecoxib

  2003cites this paper
• Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E(2) synthase gene.

  2003cites this paper
• Clinical pharmacology of etoricoxib: a novel selectiveCOX2 inhibitor

  2003cites this paper
• Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology.

  2003cites this paper
• Violence against women : impact on reproductive health and pregnancy outcome

  2003cites this paper
• The Development of Drugs That Target Cyclooxygenase-2

  2003cites this paper
• Cytokines, prostaglandins and parturition--a review.

  2003cites this paper
• Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term.

  2003cites this paper
• In vivo acquisition of hemozoin by placental blood mononuclear cells suppresses PGE2, TNF-alpha, and IL-10.

  2003cites this paper
• Glucocorticoids induce cytosolic phospholipase A2 and prostaglandin H synthase type 2 but not microsomal prostaglandin E synthase (PGES) and cytosolic PGES expression in cultured primary human amnion cells.

  2003cites this paper
• Lactosylceramide-Induced Apoptosis in Primary Amnion Cells and Amnion-Derived WISH Cells

  2002cites this paper
• Expression and localization of endothelial monocyte-activating polypeptide II in the human endometrium across the menstrual cycle: regulation of expression by prostaglandin E(2).

  2002cites this paper